Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

BulgariaBack to Bulgaria

Clinical trials in Sliven – page 6

87 clinical trials in Sliven, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Sliven at a glance
87
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

87 trials in Sliven

Open in trial search

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Acute myocardial infarction

Not recruiting

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Metabolic dysfunction-associated liver disease+2

Not recruiting

Comparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:De-oiled enriched phospholipids from soya-beans
  • Sponsor:Opella Healthcare Group S.A.S.

Hepatitis D

Not recruiting

Study on BJT-778 for Patients with Chronic Hepatitis Delta Infection

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BJT-778
  • Sponsor:Mirum Pharmaceuticals Inc.

Psoriasis

Not recruiting

Study on the Effects and Safety of Piclidenoson for Patients with Moderate-to-Severe Plaque Psoriasis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Piclidenoson
  • Sponsor:Can-Fite Biopharma Ltd.

Urinary tract infection+1

Not recruiting

Study of meropenem-vaborbactam safety and effectiveness in children aged 3 months to 12 years with complicated urinary tract infection or acute pyelonephritis

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Meropenem
  • Sponsor:Rempex Pharmaceuticals Inc.

Postoperative analgesia

Not recruiting

Study on Fentanyl Nasal Spray and Morphine for Managing Postoperative Pain in Patients After Surgery

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Fentanyl Citrate
  • Sponsor:5med GmbH

Schizophrenia

Not recruiting

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Influenza

Not recruiting

Study of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:CX-037231
  • Sponsor:Moderna Inc.

Asthma

Not recruiting

Long-term safety study of dexpramipexole tablets in patients with severe eosinophilic asthma who completed EXHALE-2 or EXHALE-3 trials

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Endocrine ophthalmopathy

Not recruiting

Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Asthma

Not recruiting

Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Sliven

What the registry says about research in the country

01 Respiratory Medicine

Clinical trials focusing on respiratory conditions including innovative treatments for asthma management and COPD. Research includes evaluation of new inhalation therapies and combination treatments.

  • Moderate to Severe Asthma
  • Chronic Obstructive Pulmonary Disease
  • Inhaler Technology Development

Studies aim to improve symptom control and quality of life for patients with chronic respiratory conditions.

02 Cardiovascular Research

Extensive research into cardiovascular diseases and related conditions, including studies on heart failure, atherosclerosis, and hypertension management.

  • Atherosclerotic Cardiovascular Disease
  • Heart Failure Management
  • Hypertriglyceridemia Treatment

Focus on preventing major cardiovascular events and improving patient outcomes through innovative therapies.

03 Immunology and Inflammation

Studies examining new treatments for autoimmune disorders and inflammatory conditions, including breakthrough therapies for various forms of arthritis.

  • Psoriatic Arthritis
  • Sjögren's Disease
  • Ulcerative Colitis

Research aims to reduce inflammation and improve disease management in chronic conditions.

04 Infectious Diseases

Research focusing on viral infections and their treatment, including studies of influenza vaccines and therapeutic approaches.

  • Influenza Prevention
  • Hepatitis Delta Treatment
  • Urinary Tract Infections

Emphasis on developing effective treatments and preventive measures for various infectious conditions.

Back to BulgariaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.